Ajanta Pharma Ltd.

2005
 -Max Healthcare to establish India`s first brain lab in New Delhi
 -Max India Ltd  Max telecom ventures Ltd signed a MoU
 
 2008
 -Max India signs agreement with UK firm for health insurance biz
 
 2012
 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every
 equity share of Rs. 2/- each to the shareholders.
 -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-
 
 
 2013
 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per
 equity share of Rs. 2/- each to the shareholders.
 -Ajanta Pharma has announces bonus in the ratio of 1:2
                                                         
 2014
 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every
 equity share of Rs. 2/- each  to the shareholders
 
 2015
 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral
 Granules 
 -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in
 US market
 -Fortune India presents award to Ajanta Pharma
 -Ajanta Pharma gets approvals for 3 ANDA's
 -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2
 
 2017
 -Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride.
 -Ajanta Pharma launches Eletriptan Hydrobromide Tablets.
 -Ajanta Pharma launches Clonidine Hydrochloride Extended Release
 Tablets in US.
 -Inaugurated & commissioned 1st phase at a New Facility in Guwahati,
 Assam, India
 - Dahej facility receives successful US FDA approval.
 
 
 2018
 -Top Export Performer Award' by the Federation of Indian Export
 Organisations. 
 -Commissioned Ajanta's 1st ever Derma facility in Guwahati.
 
 2019
 -Ajanta Pharma USA Inc. (APUI) received DIANA award for ‘Best Overall
 Generic Manufacturer’ in less than $100 mn.
 -New manufacturing facility for oral solid inaugurated at Pithampur.
 
 2020
 -Ajanta’s 1st Sterile Eye Drop Production Unit commissioned at
 Guwahati Facility.
 
 2021
 -Listed in Fortune 500 list of Indian companies Ranked 379th in
 Revenue Generation (Dec 2021).
 
 2022
 
 -The Company has issued Bonus Shares in the Ratio of 1:2.
 -Ajanta Pharma awarded 'India's Best Managed Companies' for 2022 by
 Deloitte.
 -Ajanta wins 'Maharashtra State Best Employer Brand Awards 2022' in
 Pharma sector
 -Ajanta wins Excellence in Packaging Developed in India & Packaging
 Team of the Year at India Packaging Awards 2022
 
 2023
 
 The Company has infomed that, in its  meeting  scheduled on
 10/03/2023 ,inter alia, to consider and approve the proposal for
 buyback of the equity shares of the Company and matters related /
 incidental thereto.
 
 
 -Ajanta wins 'Outstanding Export Performance Award' from Pharmexcil
 in 'Formulation' category
 
 
 -Ajanta wins 'Excellence in Pharma Supply Chain Management
 
 - Ajanta wins Times Ascent Global Best Employer Brands 2023
 
 2024
 
 -Ajanta is Great Place To Work-Certified in India for the 2nd year in
 a row
 
 -Yogesh & Rajesh Agrawal (MD & Jt. MD) recognised as 'Next Gen
 Leaders of the Year 2023' by Hurun India